These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 15467580)
1. The impact of protease inhibitors on maternal serum screening analyte levels in pregnant women who are HIV positive. Einstein FH; Wright RL; Trentacoste S; Gross S; Merkatz IR; Bernstein PS Am J Obstet Gynecol; 2004 Sep; 191(3):1004-8. PubMed ID: 15467580 [TBL] [Abstract][Full Text] [Related]
2. Maternal biochemical serum screening for Down syndrome in pregnancy with human immunodeficiency virus infection. Le Meaux JP; Tsatsaris V; Schmitz T; Fulla Y; Launay O; Goffinet F; Azria E Obstet Gynecol; 2008 Aug; 112(2 Pt 1):223-30. PubMed ID: 18669715 [TBL] [Abstract][Full Text] [Related]
3. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623 [TBL] [Abstract][Full Text] [Related]
4. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women. Sritippayawan S; Vachirasrisoontra C J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246 [TBL] [Abstract][Full Text] [Related]
5. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [TBL] [Abstract][Full Text] [Related]
6. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study. Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ; AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463 [TBL] [Abstract][Full Text] [Related]
7. Maternal serum alpha-fetoprotein and human chorionic gonadotropin levels in women with human immunodeficiency virus. Gross S; Castillo W; Crane M; Espinosa B; Carter S; DeVeaux R; Salafia C Am J Obstet Gynecol; 2003 Apr; 188(4):1052-6. PubMed ID: 12712109 [TBL] [Abstract][Full Text] [Related]
8. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD; McIntosh SF; Halstead AC Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [TBL] [Abstract][Full Text] [Related]
9. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus. Huttly W; Rudnicka A; Wald NJ Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275 [TBL] [Abstract][Full Text] [Related]
11. Multiple-marker screening in human immunodeficiency virus-positive pregnant women: Screen positivity rates with the triple and quad screens. Yudin MH; Prosen TL; Landers DV Am J Obstet Gynecol; 2003 Oct; 189(4):973-6. PubMed ID: 14586337 [TBL] [Abstract][Full Text] [Related]
12. Reliability of second trimester triple screening for Down syndrome in rhesus-negative women. Muhcu M; Mungen E; Dundar O; Bodur S; Tutuncu L; Atay V; Ozcan O; Yergok YZ J Perinatol; 2007 May; 27(5):268-71. PubMed ID: 17363912 [TBL] [Abstract][Full Text] [Related]
13. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome. Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624 [TBL] [Abstract][Full Text] [Related]
14. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)? Sancken U; Bartels I Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279 [TBL] [Abstract][Full Text] [Related]
15. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin. Bartha JL; Omar KM; Soothill PW Prenat Diagn; 2004 Aug; 24(8):609-12. PubMed ID: 15305347 [TBL] [Abstract][Full Text] [Related]
16. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies. Huang T; Boucher K; Summers AM Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787 [TBL] [Abstract][Full Text] [Related]
17. Low estriol levels in the maternal triple-marker screen as a predictor of isolated adrenocorticotropic hormone deficiency caused by a new mutation in the TPIT gene. Weintrob N; Drouin J; Vallette-Kasic S; Taub E; Marom D; Lebenthal Y; Klinger G; Bron-Harlev E; Shohat M Pediatrics; 2006 Feb; 117(2):e322-7. PubMed ID: 16390921 [TBL] [Abstract][Full Text] [Related]
18. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital. Lamlertkittikul S; Chandeying V J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410 [TBL] [Abstract][Full Text] [Related]
19. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
20. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province]. Hu YL; Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]